The newly released J-Plasma Precise 360 handpiece is designed with an angled and rotating tip to allow operating surgeons to access to structures that would be difficult to reach with straight laparoscopic devices, the Clearwater, Fla.-based company said.
“We continue to innovate J-Plasma to address specific procedures for which it is particularly well-suited. The next J-Plasma portfolio additions will include a configuration specifically designed for use in robotic surgery, developed in close collaboration with Bovie’s Medical Advisory Board, which in addition to Dr. Patel, is comprised of two prominent robotic surgeons in the fields of cardiovascular and cardiothoracic surgery,” CEO Robert Gershon said in a press release.
Bovie Medical advisory board member Dr. Vipu Patel was among the 1st to use the device, the company reported.
“By inserting the new angle tip of the Precise 360 in the ancillary port of the da Vinci robot, the surgeon gains greater access, control and precision than the straight stick versions. With this level of precision, control and safety, J-Plasma has the potential to become a standard of care in a range of procedures,” Dr. Patel said in a prepared statement.
Last October, Bovie Medical said it bought its Bulgarian R&D and manufacturing contractor for $570,000 (EU€500,000).
The deal was made for cash over a 5-year period, with an initial payment of $427,000 (EU€375,000) made at closing, and a remaining payment of $143,000 (EU€125,000) due in October, 2020, the company said.
The company said the deal will “drive operating efficiencies” that it expects will reduce operating expenses in 2016 and 2017 by an aggregate net amount of approximately $850,000.
In September, Bovie said it signed a 3-year group purchase organization agreement with Amerinetto supply its members with Bovie’s J-Plasma.